RECALL DATABASE

Capsules Recall: HANDELNINE GLOBAL Rheumacare 30-count bottle

Announced 2026-02-11 · FDA

FDA recalls Rheumacare capsules manufactured in India by Virgo UAP Pharma Pvt. Ltd., Ahmedabad, due to CGMP deviations with detected lead. Four bottles (30 capsules each) were distributed to one customer in New York. Recall numbers CAM040 (Exp 06/30/2029) and CAL079-N (Exp 09/30/2028).

BrandHANDELNINE GLOBAL LLC
ProductRheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
ReasonCGMP Deviations: product found to contain lead.
Severitycritical
Units affected4
DistributionProduct was distributed to one customer in NY.
AgencyFDA

WHAT YOU SHOULD DO

  1. Do not use the recalled Rheumacare capsules.
  2. If you have Lot CAM040 or Lot CAL079-N, stop using them and discard or return to the retailer for a refund.
  3. Check bottles for the lot numbers CAM040 or CAL079-N and follow recall instructions from HANDELNINE GLOBAL for disposal.
  4. Contact HANDELNINE GLOBAL for recall instructions and safety guidance, or monitor FDA updates for additional instructions.

How to identify the recalled item

Lot / date codesLot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
Lot / date codesLot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028

These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.

Other capsules recalls

See every capsules recall →

This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.